HUS Group, the joint authority for Helsinki and Uusimaa: contracts awarded without a rival

Updated 17 October 2026 · Finland · 2024-02-28 to 2026-05-15 · all of Finland

HUS Group, the joint authority for Helsinki and Uusimaa: contracts awarded without a rival: 19 uncontested awards; 73% of its awards; 12 suppliers; 0 single bid.

Assay record ASY-FI-05EXBBQ06H · Cite as: Assay Systems, “HUS Group, the joint authority for Helsinki and Uusimaa: contracts awarded without a rival (Finland)”, https://assay-systems.com/register/fi/uncontested/b/hus-group-the-joint-authority-for-helsinki-and-uusimaa/

1
19uncontested awards
73%of its awards
12suppliers
0single bid

HUS Group, the joint authority for Helsinki and Uusimaa made 19 of its 26 public contract awards without a rival from 2024-02-28 to 2026-05-15: 19 without a competition and 0 after a competition that drew a single bid, to 12 suppliers; the most to Novartis Finland Oy, 3.

An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.

Suppliers it awarded without a rival

Novartis Finland Oy3uncontested5awards60%of these awards

HUS Group, the joint authority for Helsinki and Uusimaa gave Novartis Finland Oy 5 awards: 3 without a competition, 0 after a competition with a single bid. First 2025-01-30, latest 2026-01-28.

Gilead Sciences Finland Oy3uncontested5awards60%of these awards

HUS Group, the joint authority for Helsinki and Uusimaa gave Gilead Sciences Finland Oy 5 awards: 3 without a competition, 0 after a competition with a single bid. First 2024-02-28, latest 2025-11-18.

Sanofi Oy2uncontested2awards100%of these awards

HUS Group, the joint authority for Helsinki and Uusimaa gave Sanofi Oy 2 awards: 2 without a competition, 0 after a competition with a single bid. First 2024-08-27, latest 2025-08-27.

Biogen Finland Oy2uncontested2awards100%of these awards

HUS Group, the joint authority for Helsinki and Uusimaa gave Biogen Finland Oy 2 awards: 2 without a competition, 0 after a competition with a single bid. First 2025-01-14, latest 2026-01-28.

Ascendis Pharma A/S2uncontested2awards100%of these awards

HUS Group, the joint authority for Helsinki and Uusimaa gave Ascendis Pharma A/S 2 awards: 2 without a competition, 0 after a competition with a single bid. First 2025-03-03, latest 2026-01-29.

BeOne Medicines, GmbH, Dutch Branch1uncontested1awards100%of these awards

HUS Group, the joint authority for Helsinki and Uusimaa gave BeOne Medicines, GmbH, Dutch Branch 1 award: 1 without a competition, 0 after a competition with a single bid. First 2026-05-15, latest 2026-05-15.

Recordati AB1uncontested1awards100%of these awards

HUS Group, the joint authority for Helsinki and Uusimaa gave Recordati AB 1 award: 1 without a competition, 0 after a competition with a single bid. First 2026-02-09, latest 2026-02-09.

MSD Finland Oy1uncontested1awards100%of these awards

HUS Group, the joint authority for Helsinki and Uusimaa gave MSD Finland Oy 1 award: 1 without a competition, 0 after a competition with a single bid. First 2026-03-11, latest 2026-03-11.

Show all 12
Oy Bristol-Myers Squibb (Finland) Ab1uncontested2awards50%of these awards

HUS Group, the joint authority for Helsinki and Uusimaa gave Oy Bristol-Myers Squibb (Finland) Ab 2 awards: 1 without a competition, 0 after a competition with a single bid. First 2024-05-02, latest 2025-11-18.

Immunocore Ireland Ltd1uncontested1awards100%of these awards

HUS Group, the joint authority for Helsinki and Uusimaa gave Immunocore Ireland Ltd 1 award: 1 without a competition, 0 after a competition with a single bid. First 2025-02-10, latest 2025-02-10.

Janssen-Cilag Oy1uncontested1awards100%of these awards

HUS Group, the joint authority for Helsinki and Uusimaa gave Janssen-Cilag Oy 1 award: 1 without a competition, 0 after a competition with a single bid. First 2025-01-14, latest 2025-01-14.

Pfizer Oy1uncontested1awards100%of these awards

HUS Group, the joint authority for Helsinki and Uusimaa gave Pfizer Oy 1 award: 1 without a competition, 0 after a competition with a single bid. First 2024-02-28, latest 2024-02-28.

Latest awards without a rival

DateSupplierHowStated reason
2026-05-15BeOne Medicines, GmbH, Dutch Branch
332458-2026
No competition
neg-wo-call
technical
2026-03-11MSD Finland Oy
169435-2026
No competition
neg-wo-call
technical
2026-02-09Recordati AB
93072-2026
No competition
neg-wo-call
technical
2026-01-29Ascendis Pharma A/S
64851-2026
No competition
neg-wo-call
technical
2026-01-28Biogen Finland Oy
64115-2026
No competition
neg-wo-call
technical
2026-01-28Novartis Finland Oy
62268-2026
No competition
neg-wo-call
unsuitable

Every uncontested award in Finland · All countries

Source: Tenders Electronic Daily (TED), Publications Office of the European Union, contract award notices. Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.